Document is current
Any future updates will be listed below
-
Authors
Noh, Hwayoung
Anota, Amélie
Mongondry, Rodolf
Meyrand, Renaud
Dupuis, Carmen
Schiffler, Camille
Marijnen, Philippe
Rinaldi, Sabina
Lachuer, Joel
Keski-Rahkonen, Pekka
Gunter, Marc J
Fléchon, Aude
Fervers, Béatrice
Pérol, Olivia
-
Funding
Funding for this research was provided by:
Institut National Du Cancer (INCa 2021-187, INCa 2021-187, INCa 2021-187, INCa 2021-187, INCa 2021-187, INCa 2021-187, INCa 2021-187, INCa 2021-187, INCa 2021-187)
- License Information
-
More Information
Article History
Received: 17 November 2023
Accepted: 2 January 2024
First Online: 15 January 2024
Declarations
:
: The study protocol was approved by the French Ethics Committee for Personal Protection (CPP, reference number: 2022-A00542-41) and registered on <i>ClinicalTrials.gov</i> (Identifier: NCT05588700). The study database was reported to the National Commission for Data Protection and Liberties (CNIL, reference number: 2016177). All participants will give written consent, dating and signing the informed consent form.
: Not applicable.
: Where authors are identified as personnel of the International Agency for Research on Cancer/World Health Organization, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy or views of the International Agency for Research on Cancer/World Health Organization.
: The authors declare no competing interests.
